Christine Nalwadda Kayemba
ID: UNCST-2020-R014220
|
ASSESSMENT OF SERVICE DELIVERY POINTS FOR REPRODUCTIVE HEALTH COMMODITIES IN UGANDA
REFNo: HS3131ES
To establish clients’ perceptions about the availability of FP services including costs borne to access services that will be asked as an exit interview.,5. To generate information on Communication Technology, method of waste disposal and user fees in the SDPs,4. To assess the availability and usability of guidelines and protocols,3. To establish staff training and supervision in the SDPs,2. To assess the supply chain (including cold chain) process of Reproductive Health commodities ,1. To generate findings on the availability and stock out of RH commodities including the availability of generic contraceptives in the Service Delivery Points (SDPs) ,To document progress in the attainment of reproductive health commodities security and delivery of quality services, in Uganda in line with FP-CIP II (2021-2025) and the FP2030 commitments. ,
|
Uganda |
2023-09-12 8:54:18 |
2026-09-12 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
.jpeg)
|
Joseph Rujumba Rujumba
ID: UNCST-2022-R011160
|
Use of penicillin prophylaxis in prevention of bacterial infections in children with sickle cell disease: a patient - caregiver preferences study in Uganda
REFNo: HS3008ES
To explore dosing and regimen preferences for penicillin prophylaxis amongst caregivers of under five children with SCD. ,To identify barriers and, enablers to PenVK prophylaxis use in under five children with SCD from the caregiver and healthcare provider perspectives,To explore the experiences of caregivers and healthcare providers concerning PenVK prophylaxis in SCD.,To explore acceptability of the present penicillin prophylaxis dosing regimen and preferences among caregivers of children with SCD less than 5 years.,
|
Uganda |
2023-09-12 8:46:06 |
2026-09-12 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Elizabeth Kemigisha Kemigisha
ID:
|
Preventing repeat adolescent pregnancy in rural Southwestern Uganda
REFNo: HS2972ES
The overall objective of this project is to prevent repeat adolescent pregnancy in rural Southwestern Uganda through exploring the underlying risk factors and piloting a targeted adolescent-friendly and age-appropriate intervention.
Specific project objectives include:
1. To assess the risks and protective factors for repeat adolescent pregnancy;
2. To co-create and pilot an intervention to prevent repeat adolescent pregnancies;
3. To evaluate feasibility, acceptability, costs and short-term effectiveness of the pilot intervention.
|
Uganda |
2023-09-12 8:41:18 |
2026-09-12 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Dennis Nabembezi
ID:
|
RESPONSIBLE, ENGAGED AND LOVING (REAL) FATHERS OUTCOME EVALUATION- BASELINE-MIDLINE AND ENDLINE SURVEYS
REFNo: SS1878ES
The initial research aim is to generate evidence on current prevalence of positive parenting practices, Intimate Partner Violence (IPV), and violent physical punishment of children. The research will answer the following research questions:
i) Assess baseline, midline and endline levels of positive parenting practices and father-child interaction.
ii) Assess baseline, midline and endline levels of harsh physical punishment of young children and IPV.
iii) Generate evidence on fathers’ gender attitudes and households’ decision-making around caregiving and child care at baseline, midline and endline.
iv) Establish baseline, midline and endline levels of early childhood development outcomes.
|
Uganda |
2023-09-12 8:39:35 |
2026-09-12 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Gorretti Nassali
ID:
|
Chemoport use in Uganda – A descriptive cross-sectional review at St. Francis Hospital Nsambya.
REFNo: HS3017ES
5. To find the early and late post-operative complications that accompanied chemoport insertion at SFHN from 2017 to 2022.,4. To document other procedures done using chemoport, chemoport management in terms of number and frequency flushing and reason for chemoport removal at SFHN from 2017 to 2022.,3. To describe the common chemoport type and size used, anaesthetic type used, common reasons for chemoport insertion, sites of insertion, average duration of procedure and perioperative complications encountered at SFHN from 2017 to 2022,2. To find the number of chemoports inserted and chemoport patient days at SFHN from 2017 to 2022. ,1. To describe the patient population (in terms of age, sex, cancer type, stage of cancer at diagnosis, chemotherapy drug administered) undergoing chemoport insertion at SFHN from 2017 to 2022.,To analyze the experience of chemoport insertion at SFHN from 2017 to 2022.,
|
Uganda |
2023-09-12 8:38:03 |
2026-09-12 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|